0.72% -0.015

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1087)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	1.545	158.87M	17.85M	-96.93M	-88.29M	-2.4735
ISRG Intuitive Surgical Inc	352.23	123.70B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	180.45	48.78B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	69.03	33.41B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.41	31.89B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	34.72	30.44B	29.14B	1.07B	1.05B	1.1956

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Gross profit of Nyxoah SA – HAM:5YI - TradingView

Price to book ratio of Nyxoah SA – HAM:5YI - TradingView

Nyxoah Begins U.S. Post-Approval Study of Genio Sleep Apnea Implant - finance.biggo.com

Cash per share of Nyxoah SA – HAM:5YI - TradingView

Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial - Yahoo Finance

symbol__ Stock Quote Price and Forecast - cnn.com

Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device - TipRanks

A sleep apnea study will implant up to 229 patients and follow them for five years - Stock Titan

The trading volume of these stocks is deviating from the norm in today's session. - ChartMill

Nyxoah SA (NYXH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Canada

Cantor Fitzgerald reiterates Nyxoah stock rating on trial success - Investing.com

Nyxoah stock rises on pivotal trial win for Genio (NYXH:NASDAQ) - Seeking Alpha

Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com India

NYXH Jumps As ACCCESS Trial Data Reset The Trading Map - timothysykes.com

NYXH Stock Jumps As ACCCESS Trial De‑Risks Sleep Apnea Bet - StocksToTrade

NYXH Stock Pops As ACCCESS Trial Data Fuels Breakout Hopes - timothysykes.com

NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story - StocksToTrade

87.7% improved on a measure of oxygen drops during sleep. No device-related serious adverse events were reported. - Stock Titan

Information on the total number of voting rights and shares - GlobeNewswire

Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateEarnings Power Value - vinanet.vn

Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseIndex Put Call - vinanet.vn

Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria

Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com

Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat

NYXH Q2 2026 Earnings: EPS Miss of 46.48% Overshadowed by 2.53% Share GainCapex Guidance - vinanet.vn

Understanding Momentum Shifts in (NYXH) - Stock Traders Daily

Nyxoah (NASDAQ: NYXH) investors report 11.0M-share, 9.9% beneficial stake - Stock Titan

Nyxoah (NYXH) Q2 2026 Earnings: Wider-than-Expected Loss Flags Cost PressuresQuarterly Profit Report - dars.gov.et

Nyxoah SA (EBR:NYXH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - webull.com

Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell - MarketBeat

A Quick Look at Today's Ratings for Nyxoah SA(NYXH.US), With a Forecast Between $2.31 to $6 - Moomoo

Nyxoah (NASDAQ:NYXH) Releases Earnings Results, Misses Expectations By $0.20 EPS - MarketBeat

Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating - marketscreener.com

Nyxoah SA Stock 12‑Month Price Target Cut to $6, Implies 326% Upside - TradingView

Nyxoah SA Revenue Breakdown – EURONEXT:NYXH - TradingView

Piper Sandler Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Nyxoah Q2 Earnings Call Highlights - MarketBeat

Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - The Manila Times

Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... - Yahoo Finance

Nyxoah SA reports results for the quarter ended June 30Earnings Summary - TradingView

Nyxoah SA (NYXHB.XD) Q2 FY2026 earnings call transcript - Yahoo Finance

NYXH: Q2 2026 revenue surged 21% sequentially, with strong U.S. growth and robust outlook - TradingView

Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside - GuruFocus

Avoiding Lag: Real-Time Signals in (NYXH) Movement - Stock Traders Daily

Nyxoah SA (NYXH) Holds at $1.45 as Sleep Apnea MedTech Stock Tests Key Support ZoneSuperTrend Flip - vinanet.vn

Nyxoah SA expected to post a loss of 42 cents a shareEarnings Preview - TradingView

NYXH Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 27%, Revenue Remains Undisclosed - vinanet.vn

Nyxoah (NYXH) Projected to Release Earnings on Wednesday - MarketBeat

Nyxoah management to discuss Q2 results in Aug. 5 webcast - Stock Titan

Nyxoah SA (NYXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH